{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T19:12:02Z","timestamp":1773774722711,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K20736"],"award-info":[{"award-number":["19K20736"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-024-00777-z","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T06:02:55Z","timestamp":1725343375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Appropriate use of triazolam in elderly patients considering a quantitative benefit-risk assessment based on the pharmacokinetic-pharmacodynamic modeling and simulation approach supported by real-world data"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5740-4346","authenticated-orcid":false,"given":"Akira","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Sera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"issue":"1","key":"777_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6\u201314.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"777_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3143\/geriatrics.40.109","volume":"40","author":"Y Tanigawara","year":"2003","unstructured":"Tanigawara Y. Recent advances in pharmacokinetics in elderly. Nihon Ronen Igakkai Zasshi. 2003;40(2):109\u201319.","journal-title":"Nihon Ronen Igakkai Zasshi"},{"issue":"12","key":"777_CR3","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s40262-016-0422-3","volume":"55","author":"JF Schlender","year":"2016","unstructured":"Schlender JF, Meyer M, Thelen K, Krauss M, Willmann S, Eissing T, et al. Development of a whole-body physiologically based Pharmacokinetic Approach to assess the pharmacokinetics of drugs in Elderly individuals. Clin Pharmacokinet. 2016;55(12):1573\u201389.","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"777_CR4","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1111\/ggi.13073","volume":"17","author":"M Guti\u00e9rrez-Valencia","year":"2017","unstructured":"Guti\u00e9rrez-Valencia M, Izquierdo M, Malafarina V, Alonso-Renedo J, Gonz\u00e1lez-Glar\u00eda B, Larrayoz-Sola B, et al. Impact of hospitalization in an acute geriatric unit on polypharmacy and potentially inappropriate prescriptions: a retrospective study. Geriatr Gerontol Int. 2017;17(12):2354\u201360.","journal-title":"Geriatr Gerontol Int"},{"issue":"4","key":"777_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1447-0594.2012.00868.x","volume":"12","author":"T Kojima","year":"2012","unstructured":"Kojima T, Akishita M, Kameyama Y, Yamaguchi K, Yamamoto H, Eto M, et al. High risk of adverse drug reactions in elderly patients taking six or more drugs: analysis of inpatient database. Geriatr Gerontol Int. 2012;12(4):761\u20132.","journal-title":"Geriatr Gerontol Int"},{"key":"777_CR6","unstructured":"Ministry of Health, Labour and Welfare. Guidance of Appropriate Medication for Elderly Patients (General). 2018. https:\/\/www.pmda.go.jp\/files\/000232249.pdf. Accessed May 1 2022."},{"key":"777_CR7","unstructured":"Ministry of Health, Labour and Welfare. Guidance of Appropriate Medication for Elderly Patients [Particular (by Recuperation Environment)]. 2019. https:\/\/www.mhlw.go.jp\/stf\/newpage_05217.html. (only in Japanese) Accessed May 1 2022."},{"issue":"6","key":"777_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.5664\/jcsm.7172","volume":"14","author":"D Patel","year":"2018","unstructured":"Patel D, Steinberg J, Patel P. Insomnia in the Elderly: a review. J Clin Sleep Med. 2018;14(6):1017\u201324.","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"777_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.amjopharm.2006.06.006","volume":"4","author":"KT Bain","year":"2006","unstructured":"Bain KT. Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother. 2006;4(2):168\u201392.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"4","key":"777_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/j.1875-9114.1988.tb04079.x","volume":"8","author":"MI Baker","year":"1988","unstructured":"Baker MI, Oleen MA. The use of benzodiazepine hypnotics in the elderly. Pharmacotherapy. 1988;8(4):241\u20137.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"777_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/0002-9343(90)90213-W","volume":"89","author":"RI Shorr","year":"1990","unstructured":"Shorr RI, Bauwens SF, Landefeld CS. Failure to limit quantities of benzodiazepine hypnotic drugs for outpatients: placing the elderly at risk. Am J Med. 1990;89(6):725\u201332.","journal-title":"Am J Med"},{"issue":"9","key":"777_CR12","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/ggi.12890","volume":"16","author":"T Kojima","year":"2016","unstructured":"Kojima T, Mizukami K, Tomita N, Arai H, Ohrui T, Eto M, et al. Screening Tool for older persons\u2019 appropriate prescriptions for Japanese: report of the Japan Geriatrics Society Working Group on Guidelines for medical treatment and its safety in the elderly. Geriatr Gerontol Int. 2016;16(9):983\u20131001.","journal-title":"Geriatr Gerontol Int"},{"issue":"5","key":"777_CR13","doi-asserted-by":"publisher","first-page":"e0127836","DOI":"10.1371\/journal.pone.0127836","volume":"10","author":"G Zhong","year":"2015","unstructured":"Zhong G, Wang Y, Zhang Y, Zhao Y. Association between Benzodiazepine Use and Dementia: a Meta-analysis. PLoS ONE. 2015;10(5):e0127836.","journal-title":"PLoS ONE"},{"issue":"7526","key":"777_CR14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","volume":"331","author":"J Glass","year":"2005","unstructured":"Glass J, Lanct\u00f4t KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331(7526):1169.","journal-title":"BMJ"},{"issue":"3","key":"777_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2125.1983.tb01503.x","volume":"15","author":"DJ Greenblatt","year":"1983","unstructured":"Greenblatt DJ, Divoll M, Abernethy DR, Moschitto LJ, Smith RB, Shader RI. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity. Br J Clin Pharmacol. 1983;15(3):303\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"777_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1172\/JCI107938","volume":"55","author":"U Klotz","year":"1975","unstructured":"Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR. The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest. 1975;55(2):347\u201359.","journal-title":"J Clin Invest"},{"issue":"5","key":"777_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.clpt.2004.07.009","volume":"76","author":"DJ Greenblatt","year":"2004","unstructured":"Greenblatt DJ, Harmatz JS, von Moltke LL, Wright CE, Shader RI. Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate. Clin Pharmacol Ther. 2004;76(5):467\u201379.","journal-title":"Clin Pharmacol Ther"},{"issue":"24","key":"777_CR18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJM199106133242403","volume":"324","author":"DJ Greenblatt","year":"1991","unstructured":"Greenblatt DJ, Harmatz JS, Shapiro L, Engelhardt N, Gouthro TA, Shader RI. Sensitivity to triazolam in the elderly. N Engl J Med. 1991;324(24):1691\u20138.","journal-title":"N Engl J Med"},{"issue":"6","key":"777_CR19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.therap.2020.02.022","volume":"75","author":"K Bihan","year":"2020","unstructured":"Bihan K, Lebrun-Vignes B, Funck-Brentano C, Salem JE. Uses of pharmacovigilance databases: an overview. Therapie. 2020;75(6):591\u20138.","journal-title":"Therapie"},{"issue":"1","key":"777_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/psp4.12479","volume":"9","author":"C Kuemmel","year":"2020","unstructured":"Kuemmel C, Yang Y, Zhang X, Florian J, Zhu H, Tegenge M, et al. Consideration of a credibility Assessment Framework in Model-Informed Drug Development: potential application to physiologically-based pharmacokinetic modeling and Simulation. CPT Pharmacometrics Syst Pharmacol. 2020;9(1):21\u20138.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"777_CR21","doi-asserted-by":"publisher","first-page":"100414","DOI":"10.1016\/j.dmpk.2021.100414","volume":"41","author":"K Maeda","year":"2021","unstructured":"Maeda K, Hisaka A, Ito K, Ohno Y, Ishiguro A, Sato R, et al. Classification of drugs for evaluating drug interaction in drug development and clinical management. Drug Metab Pharmacokinet. 2021;41:100414.","journal-title":"Drug Metab Pharmacokinet"},{"key":"777_CR22","unstructured":"Guideline on drug interaction for drug development and appropriate provision of information. https:\/\/www.pmda.go.jp\/files\/000228122.pdf. Accessed May 1 2022."},{"key":"777_CR23","unstructured":"HALCION (TRIAZOLAM). Label - FDA (https:\/\/www.accessdata.fda.gov\/, Accessed 2021-10-22)."},{"issue":"1","key":"777_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1600-0773.1989.tb00590.x","volume":"64","author":"JS Schou","year":"1989","unstructured":"Schou JS. Triazolam: adverse effects in relation to dosage. Pharmacol Toxicol. 1989;64(1):6\u20138.","journal-title":"Pharmacol Toxicol"},{"issue":"3","key":"777_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48(3):452\u20138.","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"777_CR26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/00004714-199510000-00003","volume":"15","author":"RH Barbhaiya","year":"1995","unstructured":"Barbhaiya RH, Shukla UA, Kroboth PD, Greene DS. Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam. J Clin Psychopharmacol. 1995;15(5):320\u20136.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"777_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S0009-9236(98)90176-X","volume":"64","author":"DJ Greenblatt","year":"1998","unstructured":"Greenblatt DJ, von Moltke LL, Harmatz JS, Counihan M, Graf JA, Durol AL, et al. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences. Clin Pharmacol Ther. 1998;64(3):278\u201385.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"777_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/BF00543975","volume":"32","author":"D Warot","year":"1987","unstructured":"Warot D, Bergougnan L, Lamiable D, Berlin I, Bensimon G, Danjou P, et al. Troleandomycin-triazolam interaction in healthy volunteers: pharmacokinetic and psychometric evaluation. Eur J Clin Pharmacol. 1987;32(4):389\u201393.","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"777_CR29","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1365-2125.1983.tb02256.x","volume":"16","author":"HR Ochs","year":"1983","unstructured":"Ochs HR, Greenblatt DJ, Kn\u00fcchel M. Differential effect of isoniazid on triazolam oxidation and oxazepam conjugation. Br J Clin Pharmacol. 1983;16(6):743\u20136.","journal-title":"Br J Clin Pharmacol"},{"issue":"6 Pt 1","key":"777_CR30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/clpt.1994.184","volume":"56","author":"A Varhe","year":"1994","unstructured":"Varhe A, Olkkola KT, Neuvonen PJ. Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole. Clin Pharmacol Ther. 1994;56(6 Pt 1):601\u20137.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"777_CR31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1365-2125.1996.tb00009.x","volume":"42","author":"A Varhe","year":"1996","unstructured":"Varhe A, Olkkola KT, Neuvonen PJ. Effect of fluconazole dose on the extent of fluconazole-triazolam interaction. Br J Clin Pharmacol. 1996;42(4):465\u201370.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"777_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.clpt.2005.11.009","volume":"79","author":"KE Culm-Merdek","year":"2006","unstructured":"Culm-Merdek KE, von Moltke LL, Gan L, Horan KA, Reynolds R, Harmatz JS, et al. Effect of extended exposure to grapefruit juice on cytochrome P450 3A activity in humans: comparison with ritonavir. Clin Pharmacol Ther. 2006;79(3):243\u201354.","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"777_CR33","first-page":"447","volume":"23","author":"S Pourbaix","year":"1985","unstructured":"Pourbaix S, Desager JP, Hulhoven R, Smith RB, Harvengt C. Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects. Int J Clin Pharmacol Ther Toxicol. 1985;23(8):447\u201351.","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"2","key":"777_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1067\/mcp.2001.117120","volume":"70","author":"RL O\u2019Connor-Semmes","year":"2001","unstructured":"O\u2019Connor-Semmes RL, Kersey K, Williams DH, Lam R, Koch KM. Effect of ranitidine on the pharmacokinetics of triazolam and alpha-hydroxytriazolam in both young (19\u201360 years) and older (61\u201378 years) people. Clin Pharmacol Ther. 2001;70(2):126\u201331.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"777_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1053\/cp.1999.v66.a101461","volume":"66","author":"JT Backman","year":"1999","unstructured":"Backman JT, Wang JS, Wen X, Kivist\u00f6 KT, Neuvonen PJ. Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam. Clin Pharmacol Ther. 1999;66(4):401\u20137.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"777_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0009-9236(96)90103-4","volume":"59","author":"A Varhe","year":"1996","unstructured":"Varhe A, Olkkola KT, Neuvonen PJ. Diltiazem enhances the effects of triazolam by inhibiting its metabolism. Clin Pharmacol Ther. 1996;59(4):369\u201375.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"777_CR37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s002280000156","volume":"56","author":"JJ Lilja","year":"2000","unstructured":"Lilja JJ, Kivist\u00f6 KT, Backman JT, Neuvonen PJ. Effect of grapefruit juice dose on grapefruit juice-triazolam interaction: repeated consumption prolongs triazolam half-life. Eur J Clin Pharmacol. 2000;56(5):411\u20135.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"777_CR38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/clpt.1984.240","volume":"36","author":"GP Stoehr","year":"1984","unstructured":"Stoehr GP, Kroboth PD, Juhl RP, Wender DB, Phillips JP, Smith RB. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics. Clin Pharmacol Ther. 1984;36(5):683\u201390.","journal-title":"Clin Pharmacol Ther"},{"issue":"9500","key":"777_CR39","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/S0140-6736(05)67604-0","volume":"366","author":"P Kannus","year":"2005","unstructured":"Kannus P, Siev\u00e4nen H, Palvanen M, J\u00e4rvinen T, Parkkari J. Prevention of falls and consequent injuries in elderly people. Lancet. 2005;366(9500):1885\u201393.","journal-title":"Lancet"},{"issue":"1","key":"777_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1248\/yakushi.18-00156","volume":"139","author":"C Masudo","year":"2019","unstructured":"Masudo C, Ogawa Y, Yamashita N, Mihara K. Association between Elimination Half-life of benzodiazepines and falls in the Elderly: a Meta-analysis of Observational studies. Yakugaku Zasshi. 2019;139(1):113\u201322.","journal-title":"Yakugaku Zasshi"},{"issue":"10","key":"777_CR41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/nrd1851","volume":"4","author":"LC Wienkers","year":"2005","unstructured":"Wienkers LC, Heath TG. Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov. 2005;4(10):825\u201333.","journal-title":"Nat Rev Drug Discov"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-024-00777-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T18:03:59Z","timestamp":1725386639000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-024-00777-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1186\/s40360-024-00777-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3000529\/v1","asserted-by":"object"}]},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,3]]},"assertion":[{"value":"30 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}